Daily Archives: October 29, 2015
Ipsen & Telesta Reach Deal
Ipsen and Telesta Therapeutics Inc. announced yesterday that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the treatment of high risk non-muscle invasive bladder cancer (NMIBC) in all countries of the world, … Continue reading
Darren Geliebter
Mathew Lombard
THE PRINCIPAL REGISTER 